Neuland Laboratories FY26 Results, ₹34 Dividend, Capacity Expansion

Board approved audited standalone and consolidated financial results for FY26 with unmodified audit opinion.
Recommended final dividend of ₹34 per share (340%) for FY26, payable post-shareholder approval at AGM.
Appointed Dr. Mauricio Futran as Non-Executive Non-Independent Director effective May 12, 2026.
Approved capacity expansion of 120.5 KL at Unit 1 with ₹143.4 crore investment via internal accruals and borrowings.